High glucose inhibits glucose‐6‐phosphate dehydrogenase, leading to increased oxidative stress and β‐cell apoptosis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Patients with type 2 diabetes lose β cells, but the underlying mechanisms are incompletely understood. Glucose‐6‐phosphate dehydrogenase (G6PD) is the principal source of the major intracellular reduc‐tant, NADPH, which is required by many enzymes, including enzymes of the antioxidant pathway. Previous work from our laboratory has shown that high glucose impairs G6PD activity in endothelial and kidney cells, which leads to decreased cell survival. Pancreatic β cells are highly sensitive to increased ROS. This study aimed to determine whether G6PD and NADPH play central roles in β‐cell survival. Human and mouse islets, MIN6 cell line, and G6PD deficient mice were studied. High glucose inhibited G6PD expression and activity. Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion. High glucose decreased insulin secretion, which was improved by overexpressing G6PD. G6PD‐deficient mice had smaller islets and impaired glucose tolerance compared with control mice, which suggests that G6PD deficiency per se leads to β‐cell dysfunction and death. G6PD plays an important role in β‐cell function and survival. High‐glucose‐mediated decrease in G6PD activity may provide a mechanistic explanation for the gradual loss of β cells in patients with diabetes.—Zhang, Z., Liew, C. W., Handy, D. E., Zhang, Y., Leopold, J. A., Hu, J., Guo, L., Kulkarni, R. N., Loscalzo, J., Stanton, R. C. High glucose inhibits glucose‐6‐phosphate dehydrogenase, leading to increased oxidative stress and β‐cell apoptosis. FASEB J. 24, 1497–1505 (2010). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, acquired deficiency of G6PD caused by high glucose-mediated inhibition of G6PD expression and activity increases ROS generation in pancreatic islet cells (476).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [476]
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Diabetes, oxidative stress, and antioxidants: A review
Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10058 · Cited by 3,124
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Tiedge, M., Lortz, S., Drinkgern, J., & Lenzen, S. (1997) · Diabetes · doi:10.2337/diab.46.11.1733 · Cited by 1,208
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203
Lenzen, S., Drinkgern, J., & Tiedge, M. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)02051-5 · Cited by 1,165
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · cited 2×
“Possible sources of increased ROS production in diabetes include glyceraldehyde autooxidation, increased aldose reductase reactivity and resultant decrease in NADPH, increased production of superoxide from mitochondria, and others (1, 33, 34, 38).”
Backgroundβ-Cell Glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
Robertson, R. P., Harmon, J., Tran, P. O. T., & Poitout, V. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s119 · Cited by 914
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
Cited by
Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival
Stanton, R. C. (2012) · IUBMB Life · doi:10.1002/iub.1017 · Cited by 701
“The inhibition of G6PD with antisense oligonucleotides to G6PD also produced beta cell death, whereas overexpression of G6PD rescued the cells from the increase in ROS caused by increased medium glucose (36).”
BackgroundInfluentialSelf-citationMacrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice
Khanna, S., Biswas, S., Shang, Y., Collard, E., Azad, A., Kauh, C., Bhasker, V., Gordillo, G. M., Sen, C. K., & Roy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009539 · Cited by 694
“Implication of oxidative stress in accelerating apoptosis in diabetics have been proposed [36] but is not supported by observations of the current study demonstrating the effectiveness of NAC as an antioxidant but no effect of such intervention on apoptotic cell burden at the wound site.”
ResultRedox regulation of mitochondrial function
Handy, D. E., & Loscalzo, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4123 · Cited by 588
Self-citationThe Role of the Pentose Phosphate Pathway in Diabetes and Cancer
Ge, T., Yang, J., Zhou, S., Wang, Y., Li, Y., & Tong, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00365 · Cited by 409
The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
Riganti, C., Gazzano, E., Polimeni, M., Aldieri, E., & Ghigo, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.006 · Cited by 408
“Pancreatic b cells exposed to chronically high levels of glucose have lower levels of G6PD; this change is associated with decreased amounts of NADPH, increased amounts of ROS, altered cell proliferation, and lower insulin secretion [59], suggesting a possible correlation between the impairment of G6PD activity and th…”
BackgroundGlucose-6-Phosphate Dehydrogenase Deficiency
Yaish, H. M. (2012) · Textbook of Clinical Pediatrics · doi:10.1007/978-3-642-02202-9_320 · Cited by 326
Cellular metabolic and autophagic pathways: Traffic control by redox signaling
Dodson, M., Darley-Usmar, V., & Zhang, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.014 · Cited by 324
Wang, Y.-P., Zhou, L.-S., Zhao, Y.-Z., Wang, S.-W., Chen, L.-L., Liu, L.-X., Ling, Z.-Q., Hu, F.-J., Sun, Y.-P., Zhang, J.-Y., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201387224 · Cited by 318
“Furthermore, decreased G6PD activity may predispose to the occurrence of diabetes and aldosterone-induced endothelial dysfunction (Leopold et al, 2007; Zhang et al, 2010).”
BackgroundBensellam, M., Laybutt, D. R., & Jonas, J.-C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.003 · Cited by 284
Román-Pintos, L. M., Villegas-Rivera, G., Rodríguez-Carrizalez, A. D., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3425617 · Cited by 248
“Moreover, an inhibition of glucose-6-phosphate dehydrogenase leads to an increase of free radicals through the production of nicotinamide adenine dinucleotide phosphate (NADPH), induced by hyperglycemia [75].”
BackgroundGlutathione Efflux and Cell Death
Franco, R., & Cidlowski, J. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4553 · Cited by 247
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer
Yang, H.-C., Wu, Y.-H., Yen, W.-C., Liu, H.-Y., Hwang, T.-L., Stern, A., & Chiu, D. T.-Y. (2019) · Cells · doi:10.3390/cells8091055 · Cited by 247
Pyruvate Kinase Triggers a Metabolic Feedback Loop that Controls Redox Metabolism in Respiring Cells
Grüning, N.-M., Rinnerthaler, M., Bluemlein, K., Mülleder, M., Wamelink, M. M. C., Lehrach, H., Jakobs, C., Breitenbach, M., & Ralser, M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.017 · Cited by 217
Mechanisms of distal axonal degeneration in peripheral neuropathies
Cashman, C. R., & Höke, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.048 · Cited by 199
Chen, I.-T., Aoki, T., Huang, Y.-T., Hirono, I., Chen, T.-C., Huang, J.-Y., Chang, G.-D., Lo, C.-F., & Wang, H.-C. (2011) · Journal of Virology · doi:10.1128/jvi.05385-11 · Cited by 196
Mitochondrial dysfunction and complications associated with diabetes
Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190
Xin, Y., Dominguez Gutierrez, G., Okamoto, H., Kim, J., Lee, A.-H., Adler, C., Ni, M., Yancopoulos, G. D., Murphy, A. J., & Gromada, J. (2018) · Diabetes · doi:10.2337/db18-0365 · Cited by 191
“More importantly, G6PD is the rate-limiting enzyme in the pentose phosphate pathway and increases nucleotide production favoring cell survival and proliferation (51,52).”
BackgroundLu, T.-H., Su, C.-C., Chen, Y.-W., Yang, C.-Y., Wu, C.-C., Hung, D.-Z., Chen, C.-H., Cheng, P.-W., Liu, S.-H., & Huang, C.-F. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2010.11.019 · Cited by 187
Where Metabolism Meets Senescence: Focus on Endothelial Cells
Sabbatinelli, J., Prattichizzo, F., Olivieri, F., Procopio, A. D., Rippo, M. R., & Giuliani, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01523 · Cited by 167
“…3; PKM1/PKM2, pyruvate kinase 1/2; PPP, pentose phosphate pathway; T2DM, type 2 diabetes; TCA, tricarboxylic acid; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine. also restricted, due to a cAMP-mediated impairment of glucose 6-phosphate dehydrogenase during hyperglycemia (Zhang et al., 2010).”
BackgroundMechanisms of the amplifying pathway of insulin secretion in the β cell
Kalwat, M. A., & Cobb, M. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.003 · Cited by 148
Newsholme, P., Rebelato, E., Abdulkader, F., Krause, M. D. S., Carpinelli, Â. R., & Curi, R. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0072 · Cited by 178
“Indeed, the evidence from rat islets indicates that antioxidant production acutely surpasses ROS production on exposure to glucose load, (Martens et al. 2005) and that the control of ROS levels is important for insulin secretion (Zhang et al. 2010).”
BackgroundAlnahdi, A., John, A., & Raza, H. (2019) · Nutrients · doi:10.3390/nu11091979 · Cited by 134
“Previous studies [52] have also supported these findings, suggesting an adaptation in energy metabolism to reduce the catabolic production of ATP, and perhaps suggesting that the nutrient overload might be diverting the metabolism to anabolism (increased glycogen and triglyceride synthesis) as a way to detoxify (adapt…”
ResultAlves, F. D. L., Stevenson, A. W., Baxter, E., Gillion, J. L. M., Hejazi, F., Hayes, S., MORRISON, I. E. G., Prior, B. A., McGenity, T. J., Rangel, D. E. N., et al. (2015) · Current Genetics · doi:10.1007/s00294-015-0496-8 · Cited by 142
Hecker, P. A., Leopold, J. A., Gupte, S. A., Recchia, F. A., & Stanley, W. C. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00721.2012 · Cited by 134
Self-citationPrior, R. C., Helleputte, L. V., Benoy, V., & Bosch, L. V. D. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.009 · Cited by 130
Cognitive dysfunction in diabetes: abnormal glucose metabolic regulation in the brain
Zhang, S., Zhang, Y., Wen, Z., Yang, Y., Bu, T., Bu, X., & Ni, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192602 · Cited by 157
“Suppression of G6PD and 6PGD by high glucose not only blocked the insulin secretion, but also increased oxidative stress response (95, 96).”
BackgroundSelf-citationGong, W., Zhu, G., Li, J., & Yang, X. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.020 · Cited by 106
Lei, S., Zavala-Flores, L. M., García‐García, A., Nandakumar, R., Huang, Y., Madayiputhiya, N., Stanton, R. C., Dodds, E. D., Powers, R., & Franco, R. (2014) · ACS Chemical Biology · doi:10.1021/cb400894a · Cited by 106
Self-citationSpégel, P., Sharoyko, V. V., Göhring, I., Danielsson, A. P. H., Malmgren, S., Nagorny, C. L. F., Andersson, L. E., Koeck, T., Sharp, G. W. G., Straub, S. G., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121349 · Cited by 106
Hall, E., Dekker Nitert, M., Volkov, P., Malmgren, S., Mulder, H., Bacos, K., & Ling, C. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.11.019 · Cited by 97
Anaemia, a common but often unrecognized risk in diabetic patients: A review
Angelousi, A. G., & Larger, É. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.06.001 · Cited by 112
“onversely, overexpression of G6PD in the cell line improved nsulin secretion in response to high glucose concentrations [44].”
BackgroundInfluentialReduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?
Koju, N., Qin, Z., & Sheng, R. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00838-7 · Cited by 100
“The silencing of G6PD with antisense oligonucleotides also produced beta cell death, whereas overexpression of G6PD rescued the cells from the increase in ROS caused by increased glucose in the medium [213].”
BackgroundReactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
Bhardwaj, V., & He, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103412 · Cited by 99
“The enzyme glutathione reductase reduces glutathione (GSH) in the presence of NADPH [99].”
BackgroundRedox signaling in the pancreas in health and disease
Sastre, J., Pérez, S., Sabater-Orti, L., & Rius‐Pérez, S. (2024) · Physiological Reviews · doi:10.1152/physrev.00044.2023 · Cited by 111
Hecker, P. A., Lionetti, V., Júnior, R. F. R., Rastogi, S., Brown, B. H., O’Connell, K. A., Cox, J. W., Shekar, K. C., Gamble, D., Sabbah, H. N., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.969576 · Cited by 89
“G6PD deficiency also decreased serum insulin in animals with high fructose intake, consistent with a decrease in β-cell function as reported by others (Table XII in the online-only Data Supplement).(27) Serum glucose and free fatty acids were unaffected by G6PD deficiency or TAC.”
ResultSelf-citationNutrient Metabolism, Subcellular Redox State, and Oxidative Stress in Pancreatic Islets and β-Cells
Roma, L. P., & Jonas, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.012 · Cited by 84
Arginine rich coconut kernel protein modulates diabetes in alloxan treated rats
Salil, G., Nevin, K. G., & Rajamohan, T. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.10.015 · Cited by 76
Ham, M., Choe, S. S., Shin, K. C., Choi, G., Kim, J., Noh, J., Kim, Y., Ryu, J.-W., Yoon, K., Lee, C., et al. (2016) · Diabetes · doi:10.2337/db16-0060 · Cited by 77
“Since the embryoprotective role of G6PD has been reported (20,29), various effects of G6PD deficiency on metabolic processes, immune responses, and organ development have been studied in G6PD mice (17,18,21,22,30).”
BackgroundControl of the Intracellular Redox State by Glucose Participates in the Insulin Secretion Mechanism
Rebelato, E., Abdulkader, F., Curi, R., & Carpinelli, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024507 · Cited by 73
“An increase in beta cell oxidative state impairs insulin secretion, as reported by several groups [4,12,13,14,15].”
BackgroundInfluentialThe Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage
Stancill, J. S., & Corbett, J. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718235 · Cited by 81
“Based on these data, one could imagine a potential signaling role for peroxiredoxins, potentially through a redox relay, in promoting GSIS.”
BackgroundInfluentialHao, G., Chen, H., Gu, Z., Zhang, H., Chen, W., & Chen, Y. Q. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00572-16 · Cited by 72
Control of vessel sprouting by genetic and metabolic determinants
Eelen, G., Cruys, B., Welti, J. C., Bock, K. D., & Carmeliet, P. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.08.006 · Cited by 79
Descalzo, D. L. M., Satoorian, T. S., Walker, L. M., Sparks, N. R. L., Pulyanina, P. Y., & Nieden, N. I. Z. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.06.006 · Cited by 73
“…superoxide dismutase; TBP, TATA binding protein; VitE, vitamin E; WT, wild-type. cognate receptors (Figure S1B), we sought to determine whether the Glc-induced generation of ROS (Zhang et al., 2010) and downstream cell-cycle inhibition were a potential mechanism for the Glc-induced growth defect.”
BackgroundInfluentialScoville, D. W., Cyphert, H. A., Liao, L., Xu, J., Reynolds, A., Guo, S., & Stein, R. (2015) · Diabetes · doi:10.2337/db15-0281 · Cited by 64
“The results in EndoC-βH1 cells suggest that regulation by MAFA/B:MLL3/4 of AMP-kinase subunit PRKAA1 (43), Glucose-6-Phosphate Dehydrogenase (44), and Angiotensin (AGT) (45) expression may be important (Figure 5C).”
BackgroundShadegan, M. R., & Banaee, M. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.05.177 · Cited by 64
Lentinan protects pancreatic β cells from STZ ‐induced damage
Zhang, Y., Mei, H., Shan, W., Shi, L., Chang, X., Zhu, Y., Chen, F., & Han, X. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12865 · Cited by 59
“Furthermore, increased generation of ROS activates the NF-jB pathway, which is involved in the inflammation response and endoplasmic reticulum stress response of pancreatic cells [11].”
BackgroundSelf-citationZheng, S., Zhao, M., Younan, R., Wu, Y., & Jie-ren, Y. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.031 · Cited by 57
Sharoyko, V. V., Abels, M., Sun, J., Nicholas, L. M., Mollet, I. G., Stamenkovic, J., Göhring, I., Malmgren, S., Storm, P., Fadista, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu288 · Cited by 57
“Taken together, these results show an impairment of stress responses, known to trigger cell death (20), in the severely respiratory chain-deficient b-Tfb1m islets.”
BackgroundRapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development
Liu, Y., Prentice, K. J., Eversley, J. A., Hu, C., Batchuluun, B., Leavey, K., Hansen, J. B., Wei, D. W., Cox, B., Dai, F. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.079 · Cited by 59
“We did not observe differences in expression of glucose-6-phosphate dehydrogenase (G6PD; Zhang et al., 2010), gluconolactonase (Rgn), or glutamine fructose-6-phosphate amidotransferase (Gfpt1) (Figure S2E; Kaneto”
Peiris, H. S., Raghupathi, R., Jessup, C. F., Zanin, M., Mohanasundaram, D., Mackenzie, K. D., Chataway, T., Clarke, J. N., Brealey, J. K., Coates, P. T., et al. (2012) · Endocrinology · doi:10.1210/en.2011-2149 · Cited by 58
“Oxidative stress induces apoptosis in -cells and reduces -cell proliferation (24).”
BackgroundCaveolin 1 Modulates Aldosterone‐Mediated Pathways of Glucose and Lipid Homeostasis
Baudrand, R. F., Gupta, N., Garza, A., Vaidya, A., Leopold, J. A., Hopkins, P. N., Jeunemaître, X., Ferri, C., Romero, J. R., Williams, J. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003845 · Cited by 59
Self-citationGlucose 6-phosphate dehydrogenase and the kidney
Spencer, N. Y., & Stanton, R. C. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000294 · Cited by 53
Self-citationDore, M. P., Parodi, G., Portoghese, M., & Pes, G. M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5529256 · Cited by 74
“Conversely, a decline of NADPH/NADP ratio induced by G6PD deficiency blocks the glucosestimulated insulin secretion, triggering oxidative stress and beta-cell apoptosis [111, 112].”
BackgroundG6PD Up-Regulation Promotes Pancreatic β-Cell Dysfunction
Lee, J.-W., Choi, A. H., Ham, M., Kim, J.-W., Choe, S. S., Park, J., Lee, G. Y., Yoon, K., & Kim, J. B. (2011) · Endocrinology · doi:10.1210/en.2010-0606 · Cited by 55
Harmful effects of high amounts of glucose on the immune system: An updated review
Shomali, N., Mahmoudi, J., Mahmoodpoor, A., Zamiri, R. E., Akbari, M., Hua-xi, X., & Shotorbani, S. S. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1938 · Cited by 47
Li, Y., Zheng, F., Zhang, Y., Lin, Z., Yang, J., Han, X., Feng, Y., Pei, X., Li, F., Liu, Q., et al. (2022) · FEBS Journal · doi:10.1111/febs.16614 · Cited by 48
Self-citationDiabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: From one crisis to another
Carette, C., Dubois‐Laforgue, D., Gautier, J. F., & Timsit, J. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.004 · Cited by 54
Energy Metabolism on Mitochondrial Maturation and Its Effects on Cardiomyocyte Cell Fate
Persad, K. L., & Lopaschuk, G. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.886393 · Cited by 53
Resilience to diabetic retinopathy
Serikbaeva, A., Li, Y., Ma, S., Yi, D., & Kazlauskas, A. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101271 · Cited by 51
Zhu, X. A., Yuen, M., Yan, L., Zhang, Z., Ai, F., Yang, Y., Yu, K. N., Zhu, G., Zhang, W., & Chen, X. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500990 · Cited by 49
Self-citationSoliman, A. M. (2016) · The Journal of Basic and Applied Zoology · doi:10.1016/j.jobaz.2016.01.001 · Cited by 52
Mechanisms of echinochrome potency in modulating diabetic complications in liver
Mohamed, A. S., Soliman, A. M., & Marie, M. A. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.007 · Cited by 45
Nifedipine Protects INS-1 β-Cell from High Glucose-Induced ER Stress and Apoptosis
Wang, Y., Gao, L., Li, Y., Chen, H., & Sun, Z. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12117569 · Cited by 47
High glucose–induced ubiquitination of G6PD leads to the injury of podocytes
Wang, M., Hu, J., Yan, L., Yang, Y., He, M., Wu, M., Qin, L., Gong, W., Yang, Y., Wang, Y., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801921r · Cited by 49
“Previously, we and others showed that G6PD deficiency led to increased accumulation of ROS in many cell types, which impaired their cellular function and survival (18, 21).”
BackgroundMethodSelf-citationParsanathan, R., & Jain, S. K. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.12.023 · Cited by 43
Su, X., Shou-she, L. I., Tian, Y., Zhang, Z.-Y., Zhang, G., & Wang, L. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.11.001 · Cited by 47
Self-citationGlucose-6-phosphate dehydrogenase – beyond the realm of red cell biology
Ho, H., Cheng, M.-L., & Chiu, D. T.-Y. (2014) · Free Radical Research · doi:10.3109/10715762.2014.913788 · Cited by 42
NAD kinase regulates the size of the NADPH pool and insulin secretion in pancreatic β-cells
Gray, J. P., Alavian, K. N., Jonas, E. A., & Heart, E. A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00465.2011 · Cited by 42
Glucose availability determines silver nanoparticles toxicity in HepG2
Zuberek, M., Wojciechowska, D., Krzyzanowski, D., Meczynska-Wielgosz, S., Kruszewski, M., & Grzelak, A. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0132-2 · Cited by 35
Ma, H., & Li, J. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14084 · Cited by 40
Exogenous kallikrein protects against diabetic nephropathy
Liu, W., Yang, Y., Liu, Y., Lu, X., Guo, S., Wu, M., Wang, M., Yan, L., Wang, Q., Zhao, X., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.018 · Cited by 39
Self-citationGheita, T. A., Kenawy, S. A., Sisi, R. W. E., Gheita, H. A., & Khalil, H. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.851639 · Cited by 38
Juárez, O. E., la Cruz, F. L., Leyva-Valencia, I., López-Landavery, E. A., García-Esquivel, Z., Díaz, F., Re, A. D., Vadopalas, B., & Galindo‐Sánchez, C. E. (2018) · Marine Genomics · doi:10.1016/j.margen.2018.09.003 · Cited by 41
The Pancreatic β-Cell: The Perfect Redox System
Ježek, P., Holendová, B., Jabůrek, M., Tauber, J. A., Dlasková, A., & Plecitá‐Hlavatá, L. (2021) · Antioxidants · doi:10.3390/antiox10020197 · Cited by 46
“The participation of PPP in GSIS has been previously questioned, since PPP was found to account for 10% of glucose utilization and G6PDH was found to be inhibited by increasing glucose [54,55].”
BackgroundMetabolomic analysis of pancreatic β-cell insulin release in response to glucose
Huang, M., & Joseph, J. W. (2012) · Islets · doi:10.4161/isl.20141 · Cited by 44
Mahmoud, A. A., & El-Din, A. K. A. N. (2013) · Journal of Biomarkers · doi:10.1155/2013/430813 · Cited by 38
The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers
Ahamed, A., Hosea, R., Wu, S., & Kasim, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417238 · Cited by 46
A Sustained Activation of Pancreatic NMDARs Is a Novel Factor of β-Cell Apoptosis and Dysfunction
Huang, X., Yue, S., Li, C., Huang, Y., Cheng, Q., Li, X., Hao, C., Wang, L., Xu, J.-P., Ji, M., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00366 · Cited by 37
Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
Farino, Z. J., Morgenstern, T. J., Vallaghe, J., Gregor, N., Donthamsetti, P., Harris, P. E., Pierre, N., Freyberg, R. J., Charrier‐Savournin, F., Javitch, J. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148684 · Cited by 40
NADPH Dynamics: Linking Insulin Resistance and β-Cells Ferroptosis in Diabetes Mellitus
Moon, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010342 · Cited by 38
“Zhang’s research highlights the protective role of NADPH in β -cell health, as elevated glucose levels impede G6PD activity, leading to oxidative stress and β -cell apoptosis [76].”
Contribution of Mitochondria to Insulin Secretion by Various Secretagogues
Ježek, P., Holendová, B., Jabůrek, M., Dlasková, A., & Plecitá‐Hlavatá, L. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0113 · Cited by 36
“Elevated ATP from OXPHOS fortified by FA b-oxidation and elevated cytosolic H2O2 due to the increased H2O2-release from the matrix close the KATP channel (possibly also TRPM2), as they do upon GSIS.”
BackgroundInfluentialGarcía-Domínguez, E., Carretero, A., Viña-Almunia, A., Doménech, J., González, G. O., Viña, J., & Gómez‐Cabrera, M. C. (2022) · Cells · doi:10.3390/cells11193041 · Cited by 36
Hecker, P. A., Mapanga, R. F., Kimar, C. P., Júnior, R. F. R., Brown, B. H., O’Connell, K. A., Cox, J. W., Shekar, K. C., Asemu, G., Essop, M. F., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00202.2012 · Cited by 38
“Consistent with an increase in oxidative stress, G6PD deficiency increased pancreatic -cell death and associated metabolic dysfunction in aging mice (79), increased myocardial injury following ischemia/reperfusion (28), and was associated with moderate cardiac dysfunction in older mice (27).”
BackgroundResultInfluentialDehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period
Teixeira, C. J., Veras, K. M. D. A., & Carvalho, C. R. D. O. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01842-5 · Cited by 33
Sun, Q., Zhang, B., Zhang, P., Hu, J., Zhang, H., & Xu, G. (2019) · Molecular Pain · doi:10.1177/1744806919838659 · Cited by 31
“A growing body of evidence has proved that chronic high glucose decreased the expression and activity of G6PD in different tissues, including the nervous system.(6,7) G6PD deficiency induced oxidative stress and various chronic complications, such as diabetic nephropathy and retinopathy.”
Self-citationCentrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications
Buinitskaya, Y., Gurinovich, R., Wlodaver, C. G., & Kastsiuchenka, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.584112 · Cited by 35
Glycoxidative stress–induced mitophagy modulates mitochondrial fates
Lo, M., Lu, C.-I., Chen, M., Chen, C., Lee, H.-M., & Kao, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05630.x · Cited by 29
González‐Domínguez, Á., Visiedo, F., Domínguez‐Riscart, J., Ruiz-Mateos, B., Sáez-Benito, A., Lechuga-Sancho, A. M., & Mateos, R. M. (2021) · Antioxidants · doi:10.3390/antiox10020244 · Cited by 32
“High glucose concentration-mediated impaired G6PDH activity has also been related to an increase in ROS production and reduction in cell survival in endothelial and kidney cells [51].”
BackgroundSellamuthu, P. S., Arulselvan, P., Muniappan, B. P., & Kandasamy, M. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60457-2 · Cited by 29
“The significant changes in glucose6-phosphate dehydrogenase lead to effect on cell growth and cell death[40].”
BackgroundHyperglycemia as a mechanism of pancreatic cancer metastasis
Li, W., Ma, Q., Liu, J., Han, L., Ma, G., Liu, H., Shan, T., Xie, K., & Wu, E. (2011) · Frontiers in bioscience · doi:10.2741/4017 · Cited by 29
“HG also inhibits G6PD activity and leads to the production of ROS (114).”
BackgroundSamadian, Z., Tofighi, A., Razi, M., Azar, J. T., & Pakdel, F. G. (2019) · Andrologia · doi:10.1111/and.13457 · Cited by 29
“…the cell membrane and inhibit the glucose‐6‐phosphate dehydrogenase (G6PD) activity, which in turn ultimately ends with a diminished availability of intracellular nicotinamide adenine dinucleotide phosphate (NADPH), as well as pathologic accumulation of oxidised glutathione (Zhang et al., 2010).”
BackgroundCalegari, V. C., Abrantes, J. L. F., Silveira, L. R., de Paula, F. M. M., Costa, J. M., Rafacho, A., Velloso, L. A., Carneiro, E. M., Bosqueiro, J. R., Boschero, A. C., et al. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00318.2011 · Cited by 32
Liang, H., Pan, Y., Teng, Y., Yuan, S., Wu, X., Yang, H., & Zhou, P. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1805718 · Cited by 31
Yuan, S., Ye, Z., Ye, L., Zou, J., Wu, M., Wang, K., Liao, W., & Shen, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00148 · Cited by 25
Aydemir, D., Sarayloo, E., & Ulusu, N. N. (2019) · Journal of Medical Biochemistry · doi:10.2478/jomb-2019-0041 · Cited by 25
The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions
Yaribeygi, H., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5436832 · Cited by 34
“G6PD is a crucial metabolic enzyme involved in maintaining normal cellular redox state [48, 62].”
BackgroundPhospho-ΔNp63α/SREBF1 protein interactions: Bridging cell metabolism and cisplatin chemoresistance
Huang, Y., Bell, L. N., Okamura, J., Kim, M. S., Mohney, R. P., Guerrero-Preston, R. E., & Ratovitski, E. A. (2012) · Cell Cycle · doi:10.4161/cc.22022 · Cited by 28
Zhao, J., Zhang, X., Guan, T., Wang, X., Zhang, H., Zeng, X., Dai, Q., Wang, Y., Zhou, L., & Ma, X. (2018) · Hypertension Research · doi:10.1038/s41440-018-0118-1 · Cited by 26
Gök, M., Ulusu, N. N., Tarhan, N., Tufan, C., Ozansoy, G., Arı, N., & Karasu, Ç. (2015) · Journal of Dietary Supplements · doi:10.3109/19390211.2015.1036188 · Cited by 32
“To interpret the diversity of tissue responses regulating 6PGDH against diabetic toxicity, we recall the early reports that indicated that brain and lens are highly sensitive even to low levels of hyperglycemia and NADPH than other tissues (Chandrasena et al., 2008; Dı́az-Flores et al., 2006; Takahashi et al., 2012; Z…”
BackgroundJin, K., Li, L., Sun, X., Xu, Q., Song, S., Shen, Y., & Deng, X. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8187-7 · Cited by 25
“As glycolysis and PPP serve as the initial processes and drive additional steps in cancer metabolism (Zhang et al. 2010), we focused on developing amolecular mechanistic understanding of howMEDmodulated glycolysis and the PPP in HeLa cells.”
Background
Metadata
- Authors
- Zhang, Z., Liew, C. W., Handy, D. E., Zhang, Y., Leopold, J. A., Hu, J., Guo, L., Kulkarni, R. N., Loscalzo, J., & Stanton, R. C.
- Affiliations
- Joslin Diabetes Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Stanton, Robert C.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-12-23
- Volume
- 24
- Issue
- 5
- Pages
- 1497-1505
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2879949
- OpenAlex
- W2025512372
- Cited by
- 226
- References
- 50
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 12 · 2023: 11 · 2022: 15 · 2021: 16 · 2020: 12 · 2019: 19 · 2018: 9 · 2017: 10 · 2016: 16 · 2015: 13 · 2014: 13 · 2013: 13 · 2012: 20
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01–DK54380)
- National Heart, Lung, and Blood Institute (HL 61795, N01 HV 28178, P01 HL 81857, U54 HL 070819)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucose-6-phosphate dehydrogenase, high glucose, pancreatic beta cells, beta-cell apoptosis, oxidative stress, reactive oxygen species, NADPH, type 2 diabetes, beta-cell dysfunction, insulin secretion, glucose tolerance, beta-cell survival
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Cell Line, Cell Survival, Diabetes Mellitus, Type 2, Glucosephosphate Dehydrogenase, Humans, Hyperglycemia, Insulin, Mice, Mutant Strains, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.